Antimicrobial%20Stewardship%20in%20Long%20Term%20Care - PowerPoint PPT Presentation

About This Presentation
Title:

Antimicrobial%20Stewardship%20in%20Long%20Term%20Care

Description:

Antimicrobial Stewardship in Long Term Care Marianne Pavia, MS, BS, MT(ASCP), CLS,CIC – PowerPoint PPT presentation

Number of Views:441
Avg rating:3.0/5.0
Slides: 43
Provided by: Marian295
Learn more at: https://apicnyc.org
Category:

less

Transcript and Presenter's Notes

Title: Antimicrobial%20Stewardship%20in%20Long%20Term%20Care


1
Antimicrobial Stewardship in Long Term Care
  • Marianne Pavia, MS, BS, MT(ASCP), CLS,CIC

2
Learning Objectives
  • Understand the burden of infection in LTC as
    related to the characteristics of the residents
    and the capabilities of the facility.
  • Describe the challenges and patterns of use of
    antibiotics in a LTCF.
  • Develop and apply the minimum criteria for
    initiating antimicrobial therapy in LTC.
  • Understand the uniqueness of a facility in regard
    to developing strategies for a stewardship
    program.
  • Apply CDC Campaign to prevent antimicrobial
    resistance among LTC residents.

3
Long Term Care Characteristics
  • 1.7 million residents in LTC
  • Mean age 80
  • Decreased
  • Immune function
  • Swallowing/ chewing
  • Skin integrity
  • Mobility
  • Bowel and bladder control
  • Increased
  • Acuity
  • Medications
  • Dementia/depression/apathy

4
Burden of Infection in LTC
  • 15,000 LTCFs in United States
  • Infection prevalence rate 5.3 (single day
    survey)
  • Infection incidence rate 3.6-5.2/1000 resident
    days
  • Examples
  • UTI
  • Lower respiratory, including pneumonia
  • Skin and soft tissue
  • Gastroenteritis

5
Burden of Infection in LTC
  • Higher incidence of invasive MRSA
  • MDRO more severe infections, hospitalizations,
    risk of death, cost of care
  • 12 month Rhode Island study
  • 72 inappropriate Ab, according to guidelines
  • 67 longer than recommended duration
  • Adverse drug event risk
  • Increased incidence of Cdiff
  • Gerwitz JH, Field TS, Harrold LR. Incidence and
    preventability of adverse drugevents among older
    persons in the ambulatory setting. JAMA
    2003289110711.

6
Challenges with Antimicrobial Use in LTC
  • Suspected UTIs account for 30-60 of antibiotic
    use due to diagnostic challenges
  • Clinical providers are off-site
  • Assessments communicated by front-line staff
  • Limited diagnostic testing (laboratory and
    radiology)
  • Off-site testing results in delays in specimen
    receiving, processing and results

7
Patterns of Antimicrobial Use in LTC
  • 47-80 residents exposed to one antibiotic
    course yearly.
  • Variability due to
  • Provider prescribing habits
  • Types of residents
  • Types of resident services- i.e. pulmonary team
  • Estimate of inappropriate use of Ab varies upon
    definition
  • between 25-75

8
Loeb Minimum Criteria (LMC)
  • Created in 2000, updated in 2005
  • Minimum criteria of symptoms that should be
    present before initiating antimicrobial therapy
  • Developed to
  • Decrease inappropriate use of Ab without evidence
    of infection
  • Decrease the overuse of newer, broad spectrum Ab
  • Guide rational assessment of infection
  • Proposed to improve Ab use
  • Effect of a multifaceted intervention on number
    of antimicrobial prescriptions for suspected
    urinary tract infections in residents of nursing
    homes cluster randomized controlled trial. Loeb
    M1, Brazil K, Lohfeld L, McGeer A, Simor A,
    Stevenson K, Zoutman D, Smith S, Liu X, Walter
    SD.

9
Loeb Minimum Criteria
10
Urine Culture Results Algorithm
11
Intervention LTC with Loeb Minimum Criteria
  • Sent algorithms to physicians with written
    explanatory notes
  • Mounted at nursing stations
  • Presented 6 case scenarios to staff
  • Nursing completed log of symptoms
  • Four week training period

12
LMC
13
Successful Interventions with LMC in LTC
  • Still new to LTC implementation but
  • 30 reduction in Ab use and decreased Cdiff in
    one institution that used ID consultant
  • 20 decrease in Ab that were adherent to
    guidelines from educational material ( no
    decrease in control group)
  • Jump RL, Olds DM, Seifi N, et al. Effective
    antimicrobial stewardship in a longterm care
    facility through an infectious disease
    consultation service keeping a LID on antibiotic
    use. Infect Control Hosp Epidemiol
    201233(12)118592.
  • Monette J, Miller MA, Monette M, et al. Effect
    of an educational intervention on optimizing
    antibiotic prescribing in long-term care
    facilities. J Am Geriatr Soc 20075512315.

14
Case Study
  • 92 yo female with stage 5 Alzheimers in LTC for
    severe knee arthritis, which has prevented her
    for walking for the past year. In addition, she
    suffers from depression and advanced glaucoma.
    Staff calls on-call MD noting dark and
    concentrated urine. Resident is also more
    confused but afebrile with normal vitals and no
    catheter in place. Nursing staff asks MD for a
    urine and he orders UA and culture.
  • Two days later, primary attending is called with
    urine results not knowing the clinical situation
    present on ordering. Patient is now stable and no
    fever or urinary symptoms.
  • UA mod pyuria and 1 nitrites
  • Cx- 100 K GNR

15
Case Study Questions
  • Are there minimal criteria that should be
    considered prior to initiating antibiotic
    treatment for suspected UTI in a LTC resident?
  • Is there a potential for harm when ordering urine
    tests for LTC residents in the setting on
    non-specific symptoms?
  • Is withholding an antibiotic in the presence of
    nonspecific symptoms the same as failure to
    treat?
  • What is the role of the facilitys ICP and
    medical director in reducing over-diagnosis and
    treatment of UTI?

16
Question 1 Are there minimal criteria that
should be considered prior to initiating
antibiotic treatment for suspected UTI in a LTC
resident?
  • The McGreer Criteria
  • Surveillance purposes, highly specific for
    reliable bench marching
  • Often determined retrospectively following full
    assessment
  • Not the standard for initiating antibiotics

17
(No Transcript)
18
Question 2. Is there a potential for harm when
ordering urine tests for LTC residents in the
setting on non-specific symptoms?
  • Asymptomatic Bacteriuria- prevalence rate of
    15-50 in LTC
  • Positive UA and culture in LTC regardless of
    presence of UTI
  • Over treating
  • Adverse drug reactions
  • Increase Cdiff rates
  • Increase in MDROs

19
Question 2. Is there a potential for harm when
ordering urine tests for LTC residents in the
setting on non-specific symptoms?
  • Urine tests drive decisions
  • Intervention is an algorithm to reduce
    unnecessary testing and treatment
  • Trials decrease Ab use with no negative outcomes

20
Question 3. Is withholding an antibiotic in
the presence of nonspecific symptoms the same as
failure to treat?
  • MD expected to take action
  • Worry about missing an infection, delayed
    treatment or not meeting the familys expectation
  • Observing and monitoring is taking action
  • Watchful waiting- a cornerstone of clinical
    practice

21
Question 4. What is the role of the facilitys
ICP and medical director in reducing
over-diagnosis and treatment of UTI?
  • QAPI target- safety and liability risks, costs
    and impact residents quality of life.
  • Establish minimum criteria for culturing
  • Communicate findings from antibiogram
  • Support tools for reporting change in resident
    condition (SBAR)
  • Educate resident and family as well as staff and
    MD

22
Infectious Disease Society of America (IDSA)
Guidelines
  • 2008 updates to Clinical Practice Guideline for
    the Evaluation of Fever and Infection in Older
    Adult Residents of Long-Term Care Facilities
  • Felt LMC too focused on fever
  • Fever is absent in more than one-half of LTCF
    residents with serious infection
  • Focuses on elderly with multiple chronic co
    morbidities and functional disabilities
  • Resources are typically available to evaluate
    suspected infection
  • What clinical evaluation should be performed

23
Implementing Antimicrobial Stewardship
Interventions
  • There is no one-size-fits-all approach.
  • Understand what the problem areas are at your
    institution
  • Determine what resources are available or may
    become available
  • Select stewardship strategies that best address
    the problems while accounting for the resources
  • Show off your success (or explain why success was
    not possible)
  • Use your success to secure more resources to
    address more problem areas.

24
Core Elements for Antimicrobial Stewardship
Program
  • Leadership commitment
  • Accountability for improvement
  • Need drug expertise
  • Implementing action through targeted policies and
    guidelines
  • Tracking and reporting to staff on prescribing
    and resistance
  • Identifying key participants and ASP champions
    and offer education

25
Prescriptions
  • Physicians discuss with a stewardship team member
    before prescribing
  • is usage appropriate
  • may delay initiating therapy
  • Post-prescription review
  • Best 48-72 hours or once a week

26
St. Marys Hospital for ChildrenAntimicrobial
Stewardship Program
27
SMH Stewardship Program
  • Leadership commitment- driven by CEO
  • Accountability for improvement- QAPI for medicine
  • Tracking and reporting to staff on prescribing
    and resistance
  • Implementing modified LMC/IDSA policies and
    guidelines for our population
  • 100 children- 60 trach, 10 vented, 10 short
    gut w/TPN

28
Cumulative Antibiogram
  • The primary use is for the selection of
    appropriate empiric therapy.
  • The use will result in tools to track antibiotic
    resistance as well as to assist the physician in
    making empiric antibiotic selections.
  • Limited bacteriology cultures ordered
  • 2014 created MDROs

29
SMH Stewardship Program
  • Jan 2014
  • Organized ASP Committee- Director of Pharmacy,
    Medical Director, Nursing Leadership, IC
  • Reviewed Ab use retrospectively monthly
  • Epic fail
  • April 2014
  • Reorganized, low hanging fruit

30
SMH Stewardship ProgramConjunctivitis Criteria
  • Not be due to allergy or trauma to the
    conjunctiva and one of the following
  • Pus from one or both eyes
  • New or increased conjunctival redness with or
    without itching or pain
  • If meets criteria
  • Bacterial eye culture
  • Ab treatment initiated- Fluoroquinolone drops
  • Ab discontinued in culture is negative

31
SMH Stewardship ProgramConjunctivitis
Resident Eye Cult Date Results Growth Treatment
Ana 8/30/14 9/2/14 Rare CNS, Rare Coryn sp Tobradex 8/30-9/2
Joseph 8/31/14 9/4/14 Rare Haem influenza Oflaxacin 8/31-9/07
Jason 9/4/14 9/10/14 Mod CNS Tobrex 9/5-9/10
Austin 9/12/14 9/16/14 Few Prot mirabilis, rare MSSA Oflaxacin 9/12-9/19
Adam 9/18/14 9/21/14 Many Haem influenza Cipro 9/19-9/26
Stephanie 10/2/14 10/4/14 Many Moraxella catarrhalis Cipro 10/2-10/9
Jordan 10/10/14 10/13/14 Few CNS, Few AHS Cipro 10/10-10/17
3/7 or 43 - not significant growth. Discontinue
Abs
32
SMH Stewardship ProgramRespiratory Viral Criteria
  • A case definition as follows
  • Fever 100.5ºF above AND least ONE of the
    following
  • Runny nose
  • Change in sputum
  • Shortness of breath
  • Wheezing
  • New or increased dry cough
  • Criteria met
  • RVP ordered
  • Ab treatment considered if RVP is negative and
    symptoms present

33
SMH Stewardship Program Tracheitis
  • Uncommon infectious cause of acute upper airway
    obstruction except at SMH
  • Work in progress
  • Need criteria
  • Many returns from ACF on Abs for tracheitis
    even if RVP is positive
  • Being treated with Ab that are inappropriate
  • Stop/question treatment
  • Tobi nebs

34
 Topical Antibacterial Products
Agent Uses Comment
Bactraban mupirocin impetigo (ointment) localized minor skin infections (cream) nasal formulation indicated to eradicate nasal colonization of MRSA available in ointment, cream, and nasal ointment formulations relatively expensive available by prescription
bacitracin localized minor skin infections Inexpensive available OTC

35
SMH Stewardship Program Future Work Needed
  • Attention to transmission and treatment between
    LTCFs and ACF serving the same communities
  • Increased implementation of guidelines for
    culturing and treatment
  • Better documentation
  • CLABSI de-escalating treatment
  • Approval for specific antimicrobials

36
http//www.kliinikum.ee/infektsioonikontrolliteeni
stus/doc/oppematerjalid/longterm.pdf
37
Prevent Infection
  • Step 1. Vaccinate- staff and residents
  • Step 2. Prevent conditions that lead to infection
  • aspiration, pressure ulcers, dehydration
  • Step 3. Get the unnecessary devices out
  • Insert only when essential
  • Minimize duration and reassess regularly
  • Use proper insertion and care protocols
  • Remove when no long necessary

38
Diagnose and Treat Infection Effectively
  • Step 4. Use established criteria for diagnosis
  • Target empiric therapy to likely pathogens
  • Target definitive therapy to known pathogens
  • Obtain appropriate cultures and interpret results
    with care
  • Consider Cdiff in patients with diarrhea and
    antibiotic exposure
  • Step 5. Use local resources
  • Consult infectious disease experts
  • Know what is going on in your local and regional
    area
  • Get previous updates and labs from transfer
    residents

39
Use Antimicrobials Wisely
  • Step 6. Know when to say NO
  • Minimize use of broad-spectrum antibiotics
  • Avoid long-term prophylaxis
  • Monitor antibiotic use
  • Step 7. Treat Infection, not colonization or
    contamination
  • Re-evaluate the need for Abs after 48-72 hours
  • Do not treat asymptomatic bacteriuria
  • Step 8. Stop antimicrobial treatment
  • When cultures are negative and infection unlikely
  • When infection has resolved

40
Prevent Transmission
  • Step 9. Isolate the pathogen-standard and
    transmission-based precautions
  • Step 10. Break the chain of infection
  • Step 11. Perform hand hygiene
  • Step 12. Identify residents with MDROs
  • Identify both new admissions and existing
    residents with MDROs
  • Follow standard precautions for MDRO management

41
References
  1. IDSA Guideline Kevin P. High, Suzanne F.
    Bradley, Stefan Gravenstein, David R. Mehr,
    Vincent J. Quagliarello, Chesley Richards, and
    Thomas T. Yoshikawa Clinical Practice Guideline
    for the Evaluation of Fever and Infection in
    Older Adult Residents of Long-Term Care
    Facilities 2008 Update by the Infectious
    Diseases Society of America Clin Infect Dis.
    (2009) 48 (2) 149-171 doi10.1086/595683
  2. J Am Geriatr Soc. 2007 Aug55(8)1231-5.Effect of
    an educational intervention on optimizing
    antibiotic prescribing in long-term care
    facilities. Monette J1, Miller MA, Monette M,
    Laurier C, Boivin JF, Sourial N, Le Cruguel JP,
    Vandal A, Cotton-Montpetit M.
  3. Jump RL, Olds DM, Seifi N, et al. Effective
    antimicrobial stewardship in a long term care
    facility through an infectious disease
    consultation service keeping a LID on antibiotic
    use. Infect Control Hosp Epidemiol
    201233(12)118592.
  4. Monette J, Miller MA, Monette M, et al. Effect of
    an educational intervention on optimizing
    antibiotic prescribing in long-term care
    facilities. J Am Geriatr Soc 20075512315.
  5. Stone ND, Rhee SM. Antimicrobial stewardship in
    long-term care facilities. Infect Dis Clin North
    Am, 2014 Jun 28(2)237-46. doi
    10.1016/j.idc.2014.01.001

42
Questions/Comments
Write a Comment
User Comments (0)
About PowerShow.com